Cell-mediated gene therapy for bone formation and regeneration

Current Opinion in Molecular Therapeutics

Volumn 4, Issue 4, 2002, Pages 390-394

  Turgeman, Gadi ^a   Aslan, Hadi ^a   Gazit, Zulma ^a   Gazit, Dan ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Bone formation; Bone marrow; Bone regeneration; Cell mediated gene therapy; Growth factors; Mesenchymal stem cell; Osteoprogenitor

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; OSTEOPROTEGERIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RNA DIRECTED DNA POLYMERASE;

ALBERS SCHOENBERG DISEASE; BONE CELL; BONE GROWTH; BONE REGENERATION; CELL BASED GENE THERAPY; CELL DIFFERENTIATION; CELL TYPE; DRUG EFFECT; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; HUMAN; IN VIVO STUDY; MESENCHYME CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSSIFICATION; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; REVIEW; STEM CELL; TRANSGENE;

ANIMALS; BONE DEVELOPMENT; BONE REGENERATION; GENE THERAPY; GENETIC VECTORS; HUMANS; MESODERM; MICE; OSTEOGENESIS IMPERFECTA; OSTEOPETROSIS; OSTEOPOROSIS; PROMOTER REGIONS (GENETICS); STEM CELLS;

EID: 0036705312     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S: Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res (1998) 16:155-162.
2. Valentin-Opran A, Wozney J, Csimma C, Lilly L, Riedel GE: Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop (2002) (395):110-120.
3. Yoon ST, Boden SD: Osteoinductive molecules in orthopaedics: Basic science and preclinical studies. Clin Orthop, (2002) (395):33-43.
4. Lieberman JR, Le LQ, Wu L, Finerman GA, Berk A, Witte ON, Stevenson S: Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res (1998) 16:330-339.
5. Lou J, Xu F, Merkel K, Manske P: Gene therapy: Adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res (1999) 17:43-50.
6. Engstrand T, Daluiski A, Bahamonde ME, Melhus H, Lyons KM: Transient production of bone morphogenetic protein 2 by allogeneic transplanted transduced cells induces bone formation. Hum Gene Ther (2000) 11:205-211.
7. Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P, Lee YP, Kabo JM, Finerman GA, Berk AJ, Witte ON: The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am (1999) 81:905-917.
8. Gazit D, Turgeman G, Kelley P, Wang E, Jalenak M, Zilberman Y, Moutsatsos I: Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: A novel cell-mediated gene therapy. J Gene Med (1999) 1:121-133.
9. Triffitt JT, Oreffo RO, Virdi AS, Xia Z: Osteogenic stem-cell characterization and development: Potentials for cytotherapy. Cytotherapy (2001) 3:413-416.
10. Lee JY, Musgrave D, Pelinkovic D, Fukushima K, Cummins J, Usas A, Robbins P, Fu FH, Huard J: Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am (2001) 83:1032-1039.
11. Musgrave DS, Pruchnic R, Bosch P, Ziran BH, Whalen J, Huard J: Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2. J Bone Joint Surg Br (2002) 84:120-127.
12. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science (1999) 284:143-147.
13. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R, Marshak DR, Flake AW: Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med (2000) 6:1282-1286.
14. Turgeman G, Pittman D, Müller R, Kurkalli BG, Zhou S, Pelled G, Peyser A, Zilberman Y, Gazit D: Engineered human mesenchymal stem cells: A novel platform for skeletal cell mediated gene therapy. J Gene Med (2001) 3:240-251.
15. Mankani MH, Kuznetsov SA, Fowler B, Kingman A, Robey PG: In vivo bone formation by human bone marrow stromal cells: Effect of carrier particle size and shape. Biotechnol Bioeng (2001) 72:96-101.
16. Laurencin CT, Attawia MA, Lu LQ, Borden MD, Lu HH, Gorum WJ, Lieberman JR: Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: A regional gene therapy approach to bone regeneration. Biomaterials (2001) 22:1271-1277.
17. Moutsatsos IK, Turgeman G, Zhou S, Kurkalli BG, Pelled G, Tzur L, Kelley P, Stumm N, Mi S, Müller R, Zilberman Y, Gazit D: Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther(2001) 3:449-461.
18. Oreffo RO, Virdi AS, Triffitt JT: Retroviral marking of human bone marrow fibroblasts: In vitro expansion and localization in calvarial sites after subcutaneous transplantation in vivo. J Cell Physiol (2001) 186:201-209.
19. Niyibizi C, Smith P, Mi Z, Phillips CL, Robbins P: Transfer of proα2(I) cDNA into cells of a murine model of human osteogenesis imperfecta restores synthesis of type I collagen comprised of α1 (I) and α2(I) heterotrimers in vitro and in vivo. J Cell Biochem (2001) 83:84-91.
20. Kuhlcke K, Fehse B, Schilz A, Loges S, Lindemann C, Ayuk F, Lehmann F, Stute N, Fauser AA, Zander AR, Eckert HG: Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels. Mol Ther (2002) 5:473-478.
21. Kalajzic I, Stover ML, Liu P, Kalajzic Z, Rowe DW, Lichtler AC: Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells. Virology (2001) 284:37-45.
22. Liu P, Kalajzic I, Stover ML, Rowe DW, Lichtler AC: Human bone marrow stromal cells are efficiently transduced by vesicular stomatitis virus-pseudotyped retrovectors without affecting subsequent osteoblastic differentiation. Bone (2001) 29:331-335.
23. Peng H, Chen ST, Wergedal JE, Polo JM, Yee JK, Lau KH, Baylink DJ: Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4. Mol Ther (2001) 4:95-104.
24. Stover ML, Wang CK, McKinstry MB, Kalajzic I, Gronowicz G, Clark SH, Rowe DW, Lichtler AC: Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice. Mol Ther (2001) 3:543-550.
25. Abboud SL, Woodruff K, Liu C, Shen V, Ghosh-Choudhury N: Rescue of the osteopetrotic defect in op/op mice by osteoblast-specific targeting of soluble colony-stimulating factor-1. Endocrinology (2002) 143:1942-1949.
26. Kassem M: The type I/type II model for involutional osteoporosis. In: Osteoporosis. Marcus R, Feldman D, Kelsey J (Eds), Academic Press, New York, NY, USA (1996) 34:691-702.
27. Notelovitz M: Estrogen therapy and osteoporosis: Principles & practice. Am J Med Sci (1997) 313:2-12.
28. Zhou S, Zilberman Y, Wassermann K, Bain SD, Sadovsky Y, Gazit D: Estrogen modulates estrogen receptor α and β expression, osteogenic activity and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. J Cell Biochem (2001) 81:144-155.
29. Turgeman G, Zilberman Y, Zhou S, Kelly P, Moutsatsos IK, Kharode YP, Borella LE, Bex FJ, Komm BS, Bodine PVN, Gazit D: Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice. J Cell Biochem (2002): in press.
30. Goater JJ, O'Keefe RJ, Rosier RN, Puzas JE, Schwarz EM: Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res (2002) 20:169-173.
31. Yudoh K, Matsuno H, Nakazawa F, Katayama R, Kimura T: Reconstituting telomerase activity using the telomerase catalytic subunit prevents the telomere shorting and replicative senescence in human osteoblasts. J Bone Miner Res (2001) 16:1453-1464.
32. Murray JF: Primer on the Metabolic Bone Diseases and disorders of Mineral Metabolism. Lippincott Williams & Wilkins, Philadelphia, PA, USA (1999).
33. Hoffmann A, Czichos S, Kaps C, Bachner D, Mayer H, Zilberman Y, Turgeman G, Pelled G, Gross G, Gazit D: The T-box transcription factor Brachyury mediates cartilage development in mesenchymal stem cell line C3H10T1/2. J Cell Sci (2002) 115:769-781.
34. Iyama S, Okamoto T, Sato T, Yamauchi N, Sato Y, Sasaki K, Takahashi M, Tanaka M, Adachi T, Kogawa K, Kato J et al: Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer. Arthritis Rheum (2001) 44:2160-2167.
35. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J et al Pluripotency of mesenchymal stem cells derived from adult marrow. Nature (2002) 418:41-49.
36. Varady P, Li JZ, Cunningham M, Beres EJ, Das S, Engh J, Alden TD, Pittman DD, Kerns KM, Kallmes DF, Helm GA: Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Hum Gene Ther (2001) 12:697-710.
37. Viggeswarapu M, Boden SD, Liu Y, Hair GA, Louis-Ugbo J, Murakami H, Kim HS, Mayr MT, Hutton WC, Titus L: Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo. J Bone Joint Surg Am (2001) 83:364-376.